Bristol-Myers Squibb Switzerland

Last update: August 3, 2020

Pharmaceuticals
Switzerland Its 2 main executives

Recent executive movements at Bristol-Myers Squibb

Kathryn Metcalfe, Executive Vice President, Corporate Affairs, has left the company  (news posted on December 28 2020).
Derica Rice will join the company as Independent Director on Sep. 1, 2020  (news posted on August 3 2020).
Paula Price will join the company as Independent Director on Sep. 1, 2020  (news posted on August 3 2020).

Create an alert
to follow the executive moves at Bristol-Myers Squibb Switzerland.

Most searched biographies at Bristol-Myers Squibb Switzerland

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).


Other contacts in the Pharmaceuticals industry

Learn more about the Pharmaceuticals industry >

Latest news about Bristol-Myers Squibb Switzerland

Bristol-Myers Squibb Switzerland on Wikipedia, Google News & Yahoo Finance

Bristol-Myers Squibb Switzerland on LinkedIn, Twitter & YouTube

Bristol-Myers Squibb Switzerland has 2,034 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland). Bristol-Myers Squibb Switzerland is owned by Bristol-Myers Squibb Europe.

The most constantly updated executive directory.

Companies

Companies

Learn about your clients' org charts. Understand their industries and their competitors.

Executives

Executives

View the executives' biographies. Contact the executives through our email platform.

Alerts

Alerts

Select key words to follow your clients. Receive alerts when executive movements happen.

Customers

Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.